Molecular pathology of urothelial carcinoma.

Abstract excerpt

The current personalized oncology era has witnessed significant efforts to integrate clinical, pathological, and molecular classifications. The growing need for molecular biomarkers to feed personalized oncology, together with the unprecedented wealth of knowledge on the molecular basis of bladder cancer, has led to a novel approach to this disease, incorporating molecularly generated data in clinical practice...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Carcinoma
• Share to Genetic Heterogeneity
• Share to Molecular Targeted Therapy